Aglaia BioMedical Ventures

Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities

Be the first to review

Independent rating of Aglaia BioMedical Ventures VC fund

Overall rating:
Not reviewed

About Aglaia BioMedical Ventures VC fund

Website:
http://www.aglaia-biomedical.com
Founded:
2003
Number of funds:
1
Number of investments:
10
Number of exits:
1
Headquarters:
Bilthoven, The Netherlands
Organization type:
Micro VC

How Aglaia BioMedical Ventures VC fund invests

Rounds:
Series A, Series B, Venture Round, Seed Round
Average ticket size:
4.16M USD
Smallest investment:
1.07M USD
Biggest investment:
8.61M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
The Netherlands, United States, Switzerland
Sectors of interest:
Biotechnology, Therapeutics, Pharmaceutical, Medical, Information Technology, Health Care, Life Science, 3D Technology

Portfolio - latest investments by Aglaia BioMedical Ventures VC fund
Inthera Bioscience
InteRNA Technologies
Merus
Sapreme Technologies
Mimetas
Macrophage Pharma
Cristal Therapeutics

Founders' reviews of Aglaia BioMedical Ventures VC fund

Be the first one to review Aglaia BioMedical Ventures.
Nobody reviews Aglaia BioMedical Ventures just yet. Help other founders navigate by writing about your experience with them.
Similar funds